Frost & Sullivan Recognizes Bio-Rad Laboratories, Inc.'s Digital PCR Platform, the QX200™ AutoDG™ Droplet Digital™ PCR System For New Product Innovation

MOUNTAIN VIEW, Calif., Jan. 28, 2015 /PRNewswire/ -- Based on its recent analysis of the digital PCR (dPCR) market, Frost & Sullivan recognizes Bio-Rad Laboratories, Inc. with the 2014 North American Frost & Sullivan Award for New Product Innovation. Bio-Rad's solution, the Automated Droplet Generator (AutoDG), enables a wide range of high-throughput digital PCR applications by offering walk-away automation, scalability, efficiency, and reproducibility to the dPCR workflow.

Photo - http://photos.prnewswire.com/prnh/20150113/168869

To build on its strong product portfolio in PCR and quantitative PCR (qPCR), Bio-Rad acquired Droplet Digital PCR (ddPCR) technology developer QuantaLife in 2011. This acquisition resulted in the commercialization of Bio-Rad's first-generation QX100 Droplet Digital PCR System, which set the industry standard in ease-of-use and provided traditional qPCR users with more precise and accurate quantification of nucleic acids for previously unmet needs in rare event detection, mutation and copy number analyses, and gene expression.

In July 2013, Bio-Rad launched its second-generation ddPCR instrument, the QX200 Droplet Digital PCR System. This instrument enables the use of both EvaGreen and TaqMan hydrolysis probe detection chemistries and was the first digital PCR system to provide such flexibility in experimental design. Both the QX100 and QX200 instruments have aided numerous scientific discoveries in the fields of cancer, liquid biopsy, virology, and other diseases, leading to now close to 200 peer-reviewed papers since 2011.

"Following the launch of the QX200 System, Bio-Rad extended its dominance of the market by launching the AutoDG, a fast, fully automated, walk-away instrument for generating droplets ready for transfer to the thermal cycler and, subsequently, the droplet reader," said Frost & Sullivan Senior Industry Analyst Christi Bird. "This system has huge implications for high sample throughput applications, such as cancer screening, pathogen detection, clinical diagnostics, environmental monitoring, and food testing."

The AutoDG automates the process of droplet generation, generating droplets for 96 ddPCR reactions in less than 45 minutes, a task that would require manual, hands-on time. Automating the process not only frees up researchers for other laboratory tasks, but eliminates human error and variance in pipetting, leading to more reproducible data. In addition, the scalability delivered by the AutoDG allows four to five QX100 or QX200 Droplet Readers to run continuously for the highest throughput laboratories. It also allows the plate layout to be defined by the user in increments of eight wells in instances in which all wells are not required, providing even more flexibility for various applications and throughput needs.

Bio-Rad developed the AutoDG to be simple and easy to use. The instrument features a large, color touchscreen interface and LED lighting with simple guidance for setup and loading. Oil is required to generate the droplets, and the instrument monitors and displays the oil usage levels on the touchscreen. This takes the guesswork out of reagent replacement and helps the laboratory keep its ddPCR workflow up and running efficiently.

"The AutoDG is a major milestone for Bio-Rad's ddPCR portfolio as it increases the efficiency and utility of Droplet Digital PCR in higher-throughput workflows," states Bird. "Bio-Rad continues to lead the market in breakthroughs to advance dPCR technology, earning the company a reputation for innovation and a market-leading position in the dPCR market."

For its commitment to introducing novel products to meet the wide-ranging needs of the market, Frost & Sullivan presents the 2014 New Product Innovation Award for the Digital PCR Market to Bio-Rad.

Each year, Frost & Sullivan presents this award to a company that has developed an innovative element in a product by leveraging leading-edge technologies. The award recognizes the value-added features/benefits of the product and the increased ROI it offers customers, which, in turn, increases customer acquisition and overall market penetration potential.

Frost & Sullivan's Best Practices Awards recognize companies in a variety of regional and global markets for outstanding achievement in areas such as leadership, technological innovation, customer service, and product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research.

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) develops, manufactures, and markets a broad range of innovative products and solutions for the life science research and clinical diagnostic markets. The company is renowned for its commitment to quality and customer service among university and research institutions, hospitals, public health and commercial laboratories, as well as the biotechnology, pharmaceutical, and food safety industries. Founded in 1952, Bio-Rad is based in Hercules, California, and serves more than 100,000 research and healthcare industry customers through its global network of operations. The company employs approximately 7,800 people worldwide and had revenues exceeding $2.1 billion in 2013. For more information, visit our website at www.bio-rad.com.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

• The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
• The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:        Gain access to visionary innovation

Contact:

Mireya Espinoza
P: 210.247.3870
F: 210.348.1003
E: mireya.espinoza@frost.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/frost--sullivan-recognizes-bio-rads-digital-pcr-platform-the-qx200-autodg-droplet-digital-pcr-system-for-new-product-innovation-300025901.html

SOURCE Frost & Sullivan